Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [2] (multiple letters)

E. K. Akpek, K. Karadayl, J. K. Cheetham

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)662-663
Number of pages2
JournalAmerican journal of ophthalmology
Volume128
Issue number5
DOIs
StatePublished - Jan 1 1999
Externally publishedYes

ASJC Scopus subject areas

  • Ophthalmology

Cite this